American Academy of Orthopaedic Surgeons Annual Meeting
American Academy of Orthopaedic Surgeons Annual Meeting
Perspective from Julie Y. Bishop, MD
Source/Disclosures
Source:

Hurwit D, et al. Poster 209. Presented at: American Academy of Orthopaedic Surgeons Annual Meeting; March 24-28, 2020 (meeting canceled).

Disclosures: Hurwit reports no relevant financial disclosures. Please see the full study for all other authors’ relevant financial disclosures.
July 22, 2020
1 min read
Save

Superior capsular reconstruction may be effective for irreparable rotator cuff tears

Perspective from Julie Y. Bishop, MD
Source/Disclosures
Source:

Hurwit D, et al. Poster 209. Presented at: American Academy of Orthopaedic Surgeons Annual Meeting; March 24-28, 2020 (meeting canceled).

Disclosures: Hurwit reports no relevant financial disclosures. Please see the full study for all other authors’ relevant financial disclosures.
You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Superior capsular reconstruction using a dermal allograft had positive outcome scores and a low revision rate in patients with irreparable rotator cuff tears, according to results.

Daniel Hurwit, MD, and colleagues from Hospital for Special Surgery analyzed 72 patients (mean age of 61.6 years) who underwent superior capsular reconstruction (SCR) from 2012 to 2017, 41.7% of which had a history of failed rotator cuff repair. According to the abstract, patient-reported outcomes were measured by single assessment numeric evaluation (SANE), American Shoulder and Elbow Surgeons and University of California, Los Angeles (UCLA) scores.

“All patients with available pre- and postoperative active [range of motion] demonstrated significant improvements in forward elevation (81.5° to 155.9°), abduction (46.4° to 145.9°) and external rotation (28.7° to 66.6°),” Hurwit and colleagues wrote in the abstract. “At a mean follow-up of 11.1 ± 8.4 months (range 3 [to] 33 months), postoperative patient-reported outcome scores averaged 79.7 for SANE, 78.1 for ASES and 29.7 for UCLA scores,” they added.

Five of the 72 patients required revision surgery. Four patients underwent reverse shoulder arthroplasties and one underwent revision SCR, according to the abstract.

“At short- to intermediate-term follow-up, SCR using a dermal allograft led to improvements in active ROM including forward elevation, abduction, external rotation and internal rotation, as well as favorable patient-reported outcome scores in patients with symptomatic irreparable rotator cuff tears, with a revision surgery rate of 6.9%,” Hurwit and colleagues concluded.